FDA inspection
Maiva Pharma Private Limited: FDA inspection ending Feb 20, 2026
FDA inspection 1307094 · Hosur
Key facts
| Inspection ID | 1307094 |
|---|---|
| Firm | Maiva Pharma Private Limited |
| FEI number | 3014362214 |
| Address | No 32 Sipcot Industrial Complex, Phase I |
| City | Hosur |
| Fiscal year | 2026 |
| Inspection end date | Feb 20, 2026 |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data